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Abstract
Background: To address the well-documented gap between hip and knee osteoarthritis (OA) treatment
recommendations and current clinical practice, a structured model for integrated OA care was developed and
evaluated in a stepped-wedge cluster-randomised controlled trial. The current study used secondary outcomes to
evaluate clinically important response to treatment through the Outcome Measures in Rheumatology Clinical Trials
clinical responder criteria (OMERACT-OARSI responder criteria) after 3 and 6months between patients receiving the
structured OA care model vs. usual care. Secondly, the study aimed to investigate if the proportion of responders in
the intervention group was influenced by adherence to the exercise program inherent in the model.
Methods: The study was conducted in primary healthcare in six Norwegian municipalities. General practitioners
and physiotherapists received training in OA treatment recommendations and use of the structured model. The
intervention group attended a physiotherapist-led OA education program and performed individually tailored
exercises for 8–12 weeks. The control group received usual care. Patient-reported pain, function and global
assessment of disease activity during the last week were evaluated using 11-point numeric rating scales (NRS 0–10).
These scores were used to calculate the proportion of OMERACT-OARSI responders. Two-level mixed logistic
regression models were fitted to investigate differences in responders between the intervention and control group.
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Results: Two hundred eighty-four intervention and 109 control group participants with hip and knee OA recruited
from primary care in six Norwegian municipalities. In total 47% of the intervention and 35% of the control group
participants were responders at 3 or 6 months combined; showing an uncertain between-group difference
(ORadjusted 1.38 (95% CI 0.41, 4.67). In the intervention group, 184 participants completed the exercise programme
(exercised ≥2 times/week for ≥8 weeks) and 55% of these were classified as responders. In contrast, 28% of the 86
non-completers were classified as responders.
Conclusions: The difference in proportion of OMERACT-OARSI responders at 3 and 6months between the
intervention and control group was uncertain. In the intervention group, a larger proportion of responders were
seen among the exercise completers compared to the non-completers.
Clinical trial registration: Clinicaltrials.gov identifier: NCT02333656. Registered 7. January 2015.
Keywords: Osteoarthritis, Hip, Knee, Management, RCT, Exercise, Pain, Function, Responder, Adherence
Background
There is a well-documented gap between evidence and
practice in the management of patients with hip and
knee osteoarthritis [1, 2]. The situation calls for develop-
ment and evaluation of effective OA management pro-
grammes in order to enhance the quality of OA care and
improve patient outcomes.
The international research consortium “Joint Effort Initia-
tive” has defined an OA management program as: a model
of evidence-based, non-surgical OA care implemented in a
real-world clinical setting [3]. Such models should, accord-
ing to this definition, incorporate: i) personalised, tailored
care; ii) provided as a care package with reassessments and
progression; iii) incorporate at least two of the three first-
line treatments (patient education, exercise and weight
management); and iv) include optional evidence-based ad-
junctive treatments (e.g. braces, assistive devices).
We have conducted a cluster randomized controlled
stepped-wedge trial to evaluate the effectiveness of imple-
menting a structured model of integrated OA care in six
Norwegian municipalities [4]. The previously reported pri-
mary outcome: patient-reported quality of care and associ-
ated hypotheses showed greater quality of care and
satisfaction with care, more patients referred to physiother-
apy and fewer to orthopedic surgeons, and more patients
who fulfilled physical activity criteria in the intervention
group compared to the usual care group after 6 months [5].
Another publication from this study has further reported im-
proved uptake of the first-line treatments in the intervention
group compared to the control group, but low adherence re-
garding exercise adherence in the intervention group [6].
To our knowledge, only one other previous study has
used a randomised controlled design (RCT) to test the ef-
fectiveness of an OA management program in primary
care [7]. While this study reported increased uptake of the
core NICE OA recommendations, no between-group dif-
ferences were found for any of the patient-reported out-
comes on OA related pain and function [8]. In addition, a
handful of other OA management programmes, employing
less rigorous, observational study designs have previously
been set up in a limited number of countries [9, 10]. Gen-
erally, these programmes report somewhat diverging, but
overall promising effects on pain and physical function
[11–13]. In summary, more high-quality studies to evaluate
effects of OA management programmes in primary care
are currently warranted.
It represents a common challenge for all previous
management programmes to reproduce the consistent
effects on patient-reported outcomes as found in the
more stringent exercise RCTs, which informs the treat-
ment recommendations [14, 15]. As management pro-
grammes are complex, there are multitudes of possible
reasons for this. In order to design programs that effect-
ively influence OA patients’ symptoms, it is vital to dis-
entangle some of this complexity. Such investigation can
identify and evaluate the importance of certain key com-
ponents of a programme. One such component can be
programmes’ specific strategies to improve exercise ad-
herence. High adherence is suggested to be essential to
achieve the optimal symptom-modifying effects from ex-
ercise for hip and knee OA [16]. The direct relationship
between exercise adherence and patient-reported out-
comes has not yet been investigated in any of the previ-
ous OA management programmes.[4]
The aim of the current secondary analyses (as prede-
fined in the study protocol) was to explore patient-
reported response to treatment between the intervention
and control group including application of the Outcome
Measures in Rheumatology Clinical Trials clinical re-
sponder criteria (OMERACT-OARSI responder criteria)
at 3 and 6months follow-up combined. Additionally, we
aimed to further explore the intervention group by: i)
Comparing the proportion of OMERACT-OARSI re-
sponders among participants completing the exercise
programme (exercise for ≥2 times per week for ≥8 weeks)
vs. the proportion among the non-completers; ii) Examine
demographic and baseline patient-reported measures for
associations with completing the exercise programme.
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Methods
Design
The study was a cluster-randomised controlled trial, con-
ducted with a stepped-wedge cohort design in six neigh-
bouring Norwegian municipalities (clusters) between
January 2015 and October 2017. The study involved gen-
eral practitioners (GPs), physiotherapists (PTs) and pa-
tients with symptomatic hip and knee OA. In the stepped-
wedge design all clusters started the trial simultaneously
in control phase, before switching to intervention phase in
a randomised order based on pre-defined time points. The
design is explained in detail in Fig. 1.
The study protocol has been published previously [4].
The study is reported according to the CONSORT check-
list (Additional file 2).
According to the stepped-wedge design the six muni-
cipalities (clusters) were randomly assigned to one of the
six sequences for time of cross-over from control to
intervention phase using a computer-generated list of
random numbers provided by a statistician. To ensure a
mix of municipality sizes in the randomised sequence,
stratification on the number of inhabitants (less than
versus more than 20,000) was performed. Due to the na-
ture of the intervention, it was not possible to blind the
involved GPs, PTs or patients.
Patient-reported outcomes were collected at baseline at 3
and 6month’s follow-up, using electronic questionnaires.
Participants
All GPs and all PTs working in private practice or in a
Healthy Life Centre in the six municipalities were invited
to participate in the study. Potential patients eligible for
the study were identified by their GP or PT with the fol-
lowing inclusion criteria: age ≥ 45 years with activity-
related hip and/or knee pain/complaints and clinical
signs and symptoms corresponding to hip and/or knee
OA or radiologically diagnosed OA or registered in the
medical journal with a hip or knee OA diagnosis.
Patients who did not understand the Norwegian lan-
guage; had undergone joint replacement for all affected
hip/knee OA joints; or had inflammatory rheumatic dis-
eases, malignant illness or other major conditions that
restricted their ability to adhere to the treatment recom-
mendations were excluded. Patient participants included
during the control phases constituted the control group,
whereas patient participants included during the inter-
vention phases constituted the intervention group.
Intervention
The SAMBA model for integrated OA care (Add-
itional file 1, Fig. A) was developed by the research team
and included a structured pathway for the patient
through the health care system. “SAMBA” is the acro-
nym for the Norwegian study title, “Collaboration for
improved OA care.”
The model should provide the patient with access to
timely recommended care.
Interactive workshops for GPs and PTs were the main
activity to ensure implementation of the SAMBA model
in clinical practice. The workshops were arranged separ-
ately for each municipality, in close proximity to the
time for crossover from control to intervention phase.
During the workshops, the PTs received education in
the delivery of the standardized patient-education
programme and of the individually tailored exercise
programme. The PTs received access to a database with
recommended exercises and dose recommendations.
The exercises were selected from the exercise pro-
grammes of the Swedish BOA and Danish GLA:D OA
management programmes and previously published
well-recognized, effective exercise programmes to im-
pact hip and knee OA symptoms [4, 17, 18] .
Fig. 1 The stepped-wedge cluster randomized design as applied for the SAMBA study
Moseng et al. BMC Musculoskeletal Disorders          (2020) 21:236 Page 3 of 11
The group-based patient education programme lasted
3 h and was based on a standardized template (Power-
Point with optional manuscript). The patient education
focused on providing the patient with knowledge of OA
and recommend treatments, emphasizing the import-
ance of exercise.
Following individual patient examinations, the PTs
prescribed individually tailored exercise programmes
with the main aim to improve muscular strength, in
order to reduce OA symptoms. The PTs were instructed
to closely monitor the individual patients’ performance
and to regularly adjust exercise dose and degree of diffi-
culty to facilitate progression. Dose recommendations
were based on acknowledged, international guidelines
from American College of Sports Medicine (ACSM),
and included gradually increasing the dose towards 2–4
sets with 8–12 repetitions of 60 - 70% of 1 repetition
maximum or more if tolerated [19]. The PTs were
instructed to increase the resistance when the patient
could perform 2 extra repetitions in the last set (“The 2+
principle”).
The patients performed their individual exercise pro-
grammes in groups of 5–10 patients per PT. The exer-
cise period lasted 8–12 weeks, with two supervised
weekly sessions. The patients were encouraged to add a
third home-based session consisting of 30–60min car-
diorespiratory exercise like brisk walking, running or bi-
cycling. Patients who did not wish to attend the group
sessions had the option of performing their exercise in-
dividually, but were expected to consult their PT for
regular adjustments of the programme.
During the control phase, the GPs and PTs provided
usual care for their OA patients. Usual care can be het-
erogeneous in nature and could include any treatment
the GP and patient considered appropriate. Physiother-
apy (all kind of modalities) was allowed, but not pro-
vided by a PT who had participated in the workshops.
Outcome measures
Patient-reported outcomes were evaluated at 3 and 6
months. These included pain, physical function, stiffness
and patient global assessment of disease activity during
the last week evaluated using 11-point Numeric Rating
Scales (NRS) (0 = best, 10 = worst). Hip/knee related
quality of life was evaluated with the Hip disability and
Osteoarthritis Outcome Score (HOOS) and Knee injury
and Osteoarthritis Outcome Score (KOOS), quality of
life subscale, (0–100, 100 = no problems). Daily hours
spent in sitting position was evaluated with one question
asking: “how many hours do you usually spend in sitting
position during a regular day”. The scores from the pain,
function and patient global assessment of disease activity
outcomes were used to calculate the proportion of
OMERACT-OARSI responders [20] (in the two groups)
at 3 and 6months. A participant was classified as a re-
sponder if one of the following were fulfilled:
1) High improvement in pain or function
 ≥50% improvement + absolute change of ≥2 in pain,
OR
 ≥50% improvement + absolute change of ≥2 in
function
2) Improvement in at least two of the three following:
 ≥20% improvement + absolute change ≥1 in pain
 ≥20% improvement + absolute change ≥1 in
function
 ≥20% improvement + absolute change ≥1 in the
patient global assessment of disease activity
A participant was characterized as having completed
the exercise programme if having exercised for ≥2 times
per week for ≥8 weeks. The information on the number
of completed exercise sessions was derived from partici-
pants’ exercise diaries and attendance lists from the PTs
if exercise diaries were not returned or incomplete.
Statistical analysis
Sample size calculations were not conducted for second-
ary outcomes of the study. For the main outcome, it was
calculated a need for a total of 388 participants [4].
Descriptive analyses were conducted for baseline
characteristics.
The difference in pain, function, disease activity, stiffness,
HOOS/KOOS quality of life, daily hours in sitting position
and proportion of OMERACT-OARSI responders between
the intervention and control group were investigated using
two-level mixed regression models with random effects for
cluster and individual participant and fixed effects for age,
gender, BMI and time trends (month of inclusion) on an
intention to treat basis. The linear models for pain, func-
tion, disease activity, HOOS/KOOS quality of life and daily
hours in sitting position included an interaction term of
follow-up time point and group. The difference in
OMERACT-OARSI responders at 3 and 6months was in-
vestigated using a logistic model. The proportion of re-
sponders was investigated separately for 3 and 6months
and for these time-points combined. These models account
for missing under a missing at random assumption.
In the intervention group, the difference in the propor-
tion of responders between the participants completing
the exercise programme (exercise for ≥2 times per week
for ≥8 weeks) and the non-completers were compared
using descriptive statistics.
To investigate potential associations between complet-
ing the exercise programme and baseline characteristics a
two-level mixed logistic regression was fitted. The model
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included random effects for cluster and individual partici-
pant. The set of baseline characteristics (fixed effects) were
selected based on experience and previous literature of
variables suggested to have an impact on exercise adher-
ence using a fit full model approach. The selected vari-
ables were age, gender, BMI, education (< 1 / ≥ 1 year of
university), employment (yes/no), cohabitation (yes/no),
multisite OA (yes/no), pain last week (NRS 0–10) and
self-efficacy (Arthritis Self-Efficacy Scale (ASES) mean
score of Pain and Function subscales (10–100, “very un-
certain” to “certain”) [21]. The model was additionally ad-
justed for time trends (month of inclusion), investigated
for possible multicollinearity and the goodness of fit using
Hosmer and Lemeshow test.
The significance level for the analyses was set at p < 0.05.
Patient and public involvement
Two patient research partners were members of the trial
steering group and involved in all stages of this trial includ-
ing grant application, development of study material (pa-
tient information, consent procedures, questionnaires),
intervention, interpretation and dissemination of the results.
Results
A total of 393 patients with hip and/or knee OA were in-
cluded, 109 during the control phases (=control group)
and 284 during the intervention phases (=intervention
group). Figure 2 illustrates the flow of participants through
the study and provides reasons for ineligibility or exclu-
sion. Baseline characteristics of the participants are dis-
played in Table 1.
In total 88% (n = 348) completed the patient-reported
questionnaires at 3 months, and 88% (n = 345) at 6
months follow-up (Fig. 2). Those not responding to the
questionnaires at 3 or 6months were similar to those
responding with regard to baseline characteristics. Seven
(6%) OA patients in the control group and 3 (1%) in the
intervention group received joint replacement surgery
between baseline and the 6-month follow-up.
In the intervention group, 65% (n = 184) exercised ≥2
times per week for ≥8 weeks. Four patients in the inter-
vention group experienced increased prolonged knee pain
and/or swelling and discontinued the exercise programme
at the halfway stage. Of the 102 included control group
participants, 43% self-reported having received physiother-
apy once or more between baseline and 6months.
Pain, function, disease activity and OMERACT-OARSI
responders
The mean differences in the patient-reported outcomes
and proportion of OMERACT-OARSI responders at 3
and 6months are presented in Table 2. At both 3 and 6
months the intervention group reported marginally less
pain, disease activity, and improved function compared to
the control group on the 0–10 scale. Similar results were
also seen for H/KOOS quality of life subscale, with mar-
ginally higher scores in the intervention group and slightly
less time spent in sitting position at 3 and 6months.
When applying the follow-up data to the OMERACT-
OARSI responder criteria the proportion of responders
at 3 months was 33% (n = 92) in the intervention group
compared to 23% (n = 24) in the control group. At 6
months we found 35% (n = 99) responders in the inter-
vention group compared to 23% (n = 24) responders in
the control group. When the total number of responders
at 3 and 6months was combined 47% (n = 132) in the
intervention group and 35% (n = 36) in the control group
were classified as responders.
OMERACT-OARSI responders and adherence to the
exercise programme (intervention group)
Of the 184 intervention group patients who completed
the exercise programme 55% (n = 101) were classified as
OMERACT-OARSI responders at 3 or 6months
Table 1 Baseline characteristics of patients with osteoarthritis participating in the SAMBA study
All participants Intervention group Control group
(n = 393) (n = 284) (n = 109)
Age, mean (SD) 63 (10) 63 (10) 65 (10)
Sex, female, n (%) 280 (71) 211 (74) 68 (62)
BMI, mean (SD) 29 (6) 29 (6) 28 (5)
Education
≥ 1 year university, n (%) 136 (35) 101 (36) 35 (32)
Main affected joint, n (%)
Knee 228 (58) 174 (61) 54 (49)
Hip 146 (37) 100 (35) 46 (42)
Other* 18 (6) 9 (3) 9 (8)
Multi-site OA, n (%)** 339 (86) 244 (86) 95 (87)
*OA joint other than hip and knee (e.g. hand, ankle) is the main affected joint ** ≥ 2 affected joints
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combined. For the 86 patients who did not complete the
exercise programme, 28% (n = 24) were classified as
OMERACT-OARSI responders at 3 or 6 months com-
bined. Data were missing from 14 participants. Differ-
ences in pain, physical function and disease activity
between the exercise programme completers and non-
completers at baseline and 3 and 6months follow-up are
displayed in Fig. 3. The figure indicates that the partici-
pants completing the exercise programme report more
baseline symptoms, but also have a more beneficial
symptom trajectory from baseline to 3 and 6months
compared to the non-completers.
Factors associated with completing the exercise
programme (intervention group)
Results of the logistic regression analysis to explore mea-
sures associated with completing the exercise programme
are displayed in Table 3. The variables multisite OA and
employment were removed from the model due to multi-
collinearity. In this model none of the selected variables
was significantly associated with completing the exercise
programme.
Discussion
Only small differences in mean pain, function, stiffness,
disease activity, hip/knee related quality of life and hours
spent sitting were observed between the intervention and
control group at 3 and 6months follow-up. The estimated
difference in the proportion of participants fulfilling the
OMERACT-OARSI responder criteria between the inter-
vention and control group at 3 and 6months combined was
uncertain. A larger proportion of the intervention group
participants who completed the exercise programme fulfilled
the OMERACT-OARSI responder criteria compared to the
non-completers. No demographic or baseline patient-
reported measures were significantly associated with com-
pleting the exercise programme among the intervention
group participants. The results indicate differences in the
trajectories of pain, physical function and disease activity be-
tween exercise programme completers and non-completers.
Fig. 2 Flowchart of participants’ progress through the phases of the trial. *Refers to the questions regarding pain, function and disease activity
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These results display some of the challenges and com-
plexities of implementing OA treatment recommenda-
tions in real-world clinical practice. In this study, we have
targeted the structure of care delivery, educated health
professionals and provided readily available tools to ease
the delivery of recommended treatment alternatives [4].
Unfortunately, this intervention was not sufficient to show
a clinically meaningful difference in patient-reported out-
comes and a statistically significant difference in propor-
tion of OMERACT-OARSI responders in the intervention
group compared to the usual care control group. How-
ever, the total proportion of responder in the intervention
group (47%) is similar to previous RCTs applying the
OMERACT-OARSI responder criteria to evaluate the ef-
fect of different physiotherapist led exercise interventions
on knee OA [22–24].
As much as 43% of the control group participants re-
ported receiving at least one session of physiotherapy be-
tween baseline and 6months. This could have influenced
the relative high proportion of responders in the control
group (35%) and thus contributed to the non-significant
difference in proportion of responders between the inter-
vention and control group.
When investigating the intervention group further, the
proportion of responders was higher among the partici-
pants completing the exercise programme (55%) com-
pared to the non-completers (28%). We believe this
result highlights that adherence to exercise is an import-
ant component which needs to be thoroughly addressed
to achieve the best possible results on pain and physical
function in OA management programmes [25, 26]. In
contrast, a recent study investigating adherence to a
home-exercise programme for patients with knee OA
was unable to show any relationship between exercise
adherence and pain and self-reported function [27]. Yet,
the authors were only able to use exercise frequency as a
measure of adherence, which is the similar measure we
have applied in the current analyses. In a separate paper
reporting from the SAMBA study, we showed that a large
proportion of the patients who exercised according to rec-
ommended frequency did not follow the recommenda-
tions for intensity, nor received the recommended
progression in their exercise programmes [6]. We do,
however recognize the weakness of this comparison as we
have only used descriptive statistics. Outcomes such as
psychological factors and comorbidities might be con-
founding factors in the relationship between responders
and exercise adherence [28]. However, we decided not to
perform advanced statistics on subset of data from the
current RCT, due to the a high risk of bias associated with
such analyses [29]. Two recent systematic reviews have
given evidence that not only exercise frequency but also
exercise intensity is important to impact OA symptoms in
hip and knee OA [30–32]. The combination of these
Table 2 Differences in patient-reported outcomes and OMERACT-OARSI responders between the intervention and control group at
3 and 6 months follow-up
Intervention group Control group Control vs.
intervention
3 mos. (95%
CI)
p Control vs.
intervention
6 mos. (95%
CI)
p Control vs.
Intervention
group 3 + 6
mos. (95%
CI)
p
BL
n =
283
3 mos.
n =
242
6 mos.
n =
239
3 + 6
mos.
BL
n =
109
3 mos.
n =
106
6 mos.
n =
106
3 + 6
mos.
Pain last week (NRS 0–
10), mean (SD)
5.4
(2.0)
4.4
(2.0)
4.2
(2.1)
5.1
(1.8)
4.7
(2.2)
4.7
(2.1)
b: −0.65
(−1.26,
−0.04)
0.04 b: − 0.98
(− 1.59, −
0.37)
0.002
Function last week
(NRS 0–10), mean (SD)
5.2
(2.0)
4.4
(1.9)
4.1
(2.1)
4.9
(1.9)
4.6
(2.3)
4.7
(2.1)
b: −0.67
(−1.28, −
0.06)
0.03 b: − 1.17
(− 1.78, −
0.56)
<
0.001
Disease activity last
week (NRS 0–10),
mean (SD)
5.3
(2.0)
4.3
(2.0)
4.2
(2.1)
4.8
(2.0)
4.7
(2.3)
4.7
(2.2)
b: −0.93
(−1.55, −
0.31)
0.003 b: − 1.02
(− 1.64, −
0.39)
0.001
OMERACT-OARSI
responders, n (%)
92
(33)
99
(35)
132
(47)
24
(23)
24
(23)
36
(35)
OR: 1.37
(0.26, 7.24)
0.7 OR: 2.81
(0.32, 24.67)
0.3 OR: 1.38
(0.41, 4.67)
0.6
Stiffness last week
(NRS 0–10), mean (SD)
5.3
(2.3)
4.5
(2.1)
4.3
(2.1)
4.9
(2.2)
4.6
(2.1)
4.9
(2.1)
b: −0.63
(−1.28, 0.01)
0.05 b: − 1.10
(− 1.74, −
0.45)
0.001
H/KOOS QoL subscale
mean (SD)
44.9
(16.3)
47.8
(14.9)
49.7
(15.8)
49.9
(17.2)
45.3
(18.2)
47.2
(17.5)
b: 5.43
(0.59, 10.27)
0.03 b: 5.11
(0.28, 9.95)
0.04
Daily hours in sitting
position, mean (SD)
6.5
(2.8)
6.1
(2.8)
5.9
(2.6)
6.8
(3.6)
6.4
(3.2)
6.2
(3.0)
b:-1.17
(−2.04,
−0.31)
0.008 b: −1.47
(− 2.33, −
0.60)
0.001
b Beta. OR Odds Ratio. Estimates are adjusted for patient age, sex, BMI and study months (number of months between study initiation and the patients’ baseline
questionnaire). H/KOOS QoL = Hip disability and Osteoarthritis Outcome Score/ Knee injury and Osteoarthritis Outcome Score, Quality of Life subscale, (0–100.
100 = no problems)
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Fig. 3 Difference in OA related pain, function and disease activity between exercise program completers (exercised ≥2 times per week for ≥8
weeks) and non-completers
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findings suggests that the proportion of responders in the
intervention group could have been higher if more partici-
pants followed the ACSM recommendations on both ex-
ercise frequency and intensity [19]. However, improved
adherence to exercise in clinical practice is not easily
achieved. Previous studies have found small effects of cer-
tain behaviour change techniques and booster sessions to
improve exercise adherence among patients [33, 34]. How
to effectively improve exercise adherence in patients with
hip and knee OA is a current research priority [35], which
should be further studied also within the current setting.
Patient motivation and beliefs may be important factors to
consider [36].v
None of the demographic or baseline patient-reported
measures were significantly associated with completing the
exercise programme among the intervention group partici-
pants. A previous study has pointed to low-income and no
baseline pain with pivoting and twisting as predictors for
non-adherence to exercise in patients with meniscal tears
and knee osteoarthritis [37]. Our data also indicates that
participants not completing the exercise programme have a
lower symptom burden at baseline compared to the com-
pleters. It is however, unknown if the participants complet-
ing the exercise program had a better response due to the
higher symptom burden at baseline or due to completing
the exercise program. For future studies it is relevant to
examine this relationship further.
Strengths and limitations
A major strength of this study is the randomised con-
trolled design, combined with the broad inclusion criteria
and pragmatic set-up. This combination provides a high
external validity of the results toward real-life clinical
practice. The usual care control group made it possible to
form valid conclusions of the effectiveness of the SAMBA
model regarding difference in proportion of responders
between the intervention and control group. Another
strength was the application of the OMERACT-OARSI re-
sponder criteria which is a recommended tool to assess
change in OA symptoms after non-pharmacological inter-
ventions both in research and clinical practice [38].
Our study also holds some limitations which should be
considered. Firstly, the analyses were conducted from sec-
ondary outcomes of an RCT. Power calculations were not
performed for these outcomes. Secondly, our measure of
adherence was a mix between data from patients’ self-
reported exercise diaries and the physiotherapists’ attend-
ance lists. It is known that people tend to overestimate ex-
ercise behaviour [39]. On the other hand, it is also possible
that participants would sometimes forget to record their ex-
ercise sessions. Patients could also have exercised at home,
which the PTs would not be able to document on their at-
tendance lists. It is therefore a risk that exercise adherence
could be both over- and underestimated. Due to this limita-
tion we chose not to conduct a more sophisticated statis-
tical analysis on the influence of exercise adherence on the
proportion of responders. Methods such as a complier
average causal effect analysis could have been appropriate if
such methods had been developed for cluster-randomized
stepped-wedge trials. Thirdly, the size of the groups is un-
balanced due to a higher recruitment rate during the inter-
vention phases of the study. As potential patient
participants were identified by their GP and PT, it is pos-
sible that a recruitment bias exists.
Conclusions
To conclude, we found an uncertain difference between
the proportion of OMERACT-OARSI responders in the
intervention and control group at 3 and 6months com-
bined. In the intervention group, the proportion of re-
sponders was higher among the completers of the
exercise programme vs. the non-completers. None of the
selected demographic or patient-reported baseline vari-
ables was associated with completing the exercise
programme among the intervention group participants.
Hence, exercise adherence may be an important contrib-
uting factor to achieve patient-reported effects within
OA care models in primary care.
Table 3 Association between exercise programme completers and selected baseline variables
Variable Completer n = 184 Non-Completer
n = 86
Adjusted OR (95% CI) p
Age, mean (SD) 63.4 (9.5) 61.3 (9.8) 1.02 (0.98, 1.05) 0.2
Sex, female, n (%) 141 (77.0) 62 (72.1) 1.60 (0.86, 3.00) 0.1
BMI, mean (SD) 28.5 (5.5) 29.8 (5.9) 0.97 (0.92, 1.02) 0.2
Education, ≥ 1 year university, n (%) 65 (35.7) 28 (32.9) 1.07 (0.60, 1.91) 0.8
Living with someone, n (%) 144 (78.7) 66 (77.6) 1.25 (0.63, 2.45) 0.5
Self-efficacy (10 worst-100 best), mean (SD) 57.9 (17.6) 55.5 (21.1) 1.01 (0.99, 1.02) 0.4
Pain (NRS 0–10), mean (SD) 5.2 (1.9) 5.7 (2.1) 0.94 (0.80, 1.09) 0.4
The model includes random effects of cluster and individual participant and fixed effects for the other included variables and with additional adjustments for time
(month of inclusion). OR = Odds ratio
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